Hepatitis C guidance 2018 update: Aasld-idsa recommendations for testing, managing, and treating Hepatitis C Virus infection

Raymond T. Chung, Marc G. Ghany, Arthur Y. Kim*, Kristen M. Marks, Susanna Naggie, Hugo E. Vargas, Andrew I. Aronsohn, Debika Bhattacharya, Tina Broder, Oluwaseun O. Falade-Nwulia, Robert J. Fontana, Stuart C. Gordon, Theo Heller, Scott D. Holmberg, Ravi Jhaveri, Maureen M. Jonas, Jennifer J. Kiser, Benjamin P. Linas, Vincent Lo Re, Timothy R. MorganRonald G. Nahass, Marion G. Peters, K. Rajender Reddy, Andrew Reynolds, John D. Scott, Gloria Searson, Tracy Swan, Norah A. Terrault, Stacey B. Trooskin, John B. Wong, Kimberly A. Workowski

*Corresponding author for this work

Research output: Contribution to journalArticle

165 Scopus citations

Abstract

Recognizing the importance of timely guidance regarding the rapidly evolving field of hepatitis C management, the American Association for the Study of Liver Diseases (AASLD) and the Infectious Diseases Society of America (IDSA) developed a web-based process for the expeditious formulation and dissemination of evidence-based recommendations. Launched in 2014, the hepatitis C virus (HCV) guidance website undergoes periodic updates as necessitated by availability of new therapeutic agents and/or research data. A major update was released electronically in September 2017, prompted primarily by approval of new direct-acting antiviral agents and expansion of the guidance's scope. This update summarizes the latest release of the HCV guidance and focuses on new or amended recommendations since the previous September 2015 print publication. The recommendations herein were developed by volunteer hepatology and infectious disease experts representing AASLD and IDSA and have been peer reviewed and approved by each society's governing board.

Original languageEnglish (US)
Pages (from-to)1477-1492
Number of pages16
JournalClinical Infectious Diseases
Volume67
Issue number10
DOIs
StatePublished - Oct 30 2018

Keywords

  • HCV guidance
  • chronic HCV treatment
  • direct-acting antiviral treatment
  • hepatitis C

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Hepatitis C guidance 2018 update: Aasld-idsa recommendations for testing, managing, and treating Hepatitis C Virus infection'. Together they form a unique fingerprint.

  • Cite this

    Chung, R. T., Ghany, M. G., Kim, A. Y., Marks, K. M., Naggie, S., Vargas, H. E., Aronsohn, A. I., Bhattacharya, D., Broder, T., Falade-Nwulia, O. O., Fontana, R. J., Gordon, S. C., Heller, T., Holmberg, S. D., Jhaveri, R., Jonas, M. M., Kiser, J. J., Linas, B. P., Lo Re, V., ... Workowski, K. A. (2018). Hepatitis C guidance 2018 update: Aasld-idsa recommendations for testing, managing, and treating Hepatitis C Virus infection. Clinical Infectious Diseases, 67(10), 1477-1492. https://doi.org/10.1093/cid/ciy585